Intec Pharma to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Date:
Company Presentation:
Presenter:
Format: Fireside Chat and One-on-One Investor Meetings
About Intec Pharma Ltd.
Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism. The Company's product pipeline includes two product candidates in clinical trial stages: Accordion Pill Carbidopa/Levodopa, or AP-CD/LD, which is in late-stage Phase 3 development for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients, and AP-cannabinoids, an Accordion Pill to deliver either or both of the primary cannabinoids contained in Cannabis sativa, cannabidiol (CBD) and tetrahydrocannabinol (THC) for various pain indications. In addition, the Company has a research collaboration with Merck & Co.
For more information, visit www.intecpharma.com. Intec Pharma routinely posts information that may be important to investors in the Investor Relations section of its website.
Intec Pharma Investor Contact:
Stern IR
+1 212-362-1200
will@sternir.com
View original content:http://www.prnewswire.com/news-releases/intec-pharma-to-present-at-oppenheimer-fall-healthcare-life-sciences--medtech-summit-301130396.html
SOURCE